Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Nunan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nuclear Medicine Communications|October 1, 1991
Why clinical PET?D Croft, T Nunan, M Maisey
Nuclear Medicine Communications|September 1, 1988
Nuclear medicine and AIDSM J O'Doherty, T Nunan, H O'Doshenty
Nuclear Medicine Communications|April 4, 2003
Nuclear medicine and radionuclide imaging: a survey of recruitment issues in the United KingdomH W Gray, E Prvulovich, T Nunan
Clinical Nuclear Medicine|January 1, 1996
The use of low-dose intravenous insulin in clinical myocardial F-18 FDG PET scanningP Lewis, T Nunan, A Dynes, et al.
The British Journal of Radiology|October 23, 2010
Incidental fleurodeoxyglucose uptake in the prostateW L Wong, R N Moule, T Nunan
International Journal of Clinical Practice. Supplement|May 7, 2005
Misinterpretation of radioisotope imaging in pelvic kidneysD Allen, M F Bultitude, T Nunan, et al.
European Journal of Haematology|April 1, 1990
Haemophilia, AIDS and lung epithelial permeabilityM J O'Doherty, C J Page, C Harrington, et al.
Thorax|June 1, 1990
Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fillM O'Doherty, S Thomas, C Page, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphomaM Hutchings, N G Mikhaeel, P A Fields, et al.
Lancet (London, England)|November 5, 1994
Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancerP Lewis, S Griffin, P Marsden, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nuclear Medicine Communications|October 1, 1991
Why clinical PET?D Croft, T Nunan, M Maisey
Nuclear Medicine Communications|September 1, 1988
Nuclear medicine and AIDSM J O'Doherty, T Nunan, H O'Doshenty
Nuclear Medicine Communications|April 4, 2003
Nuclear medicine and radionuclide imaging: a survey of recruitment issues in the United KingdomH W Gray, E Prvulovich, T Nunan
Clinical Nuclear Medicine|January 1, 1996
The use of low-dose intravenous insulin in clinical myocardial F-18 FDG PET scanningP Lewis, T Nunan, A Dynes, et al.
The British Journal of Radiology|October 23, 2010
Incidental fleurodeoxyglucose uptake in the prostateW L Wong, R N Moule, T Nunan
International Journal of Clinical Practice. Supplement|May 7, 2005
Misinterpretation of radioisotope imaging in pelvic kidneysD Allen, M F Bultitude, T Nunan, et al.
European Journal of Haematology|April 1, 1990
Haemophilia, AIDS and lung epithelial permeabilityM J O'Doherty, C J Page, C Harrington, et al.
Thorax|June 1, 1990
Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fillM O'Doherty, S Thomas, C Page, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphomaM Hutchings, N G Mikhaeel, P A Fields, et al.
Lancet (London, England)|November 5, 1994
Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancerP Lewis, S Griffin, P Marsden, et al.
Pageof 2